Related Experiment Video
Updated: Aug 30, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Vaccines and Bell's palsy: A narrative review
Blandine Bertin1, Guillaume Grenet2, Véronique Pizzoglio-Billaudaz1
1Pharmacovigilance Center, Hospital University Pharmacotoxicology Department, Hospices civils de Lyon, 69003 Lyon, France.
Abstract:
The association between vaccines and peripheral facial palsy (PFP), an issue that has been the subject of debate for many years, has been raised again following results of clinical trials assessing mRNA based COVID-19 vaccines. To review the available literature on this topic, PubMed was searched from inception until February 25, 2022. Inclusion criteria were case reports with documented rechallenge and comparative epidemiological studies. Cases of COVID-19 vaccine-induced PFP with available data on vaccine rechallenge were also identified from Vigibase until December 31, 2021. Of the 347 articles retrieved, 32 comparative epidemiological studies, 1 meta-analysis and 4 case reports met our criteria, of which 13 involved COVID-19 vaccines. Eight studies found an association between at least one vaccine and the occurrence of PFP, whereas 24 did not. Positive studies involved seasonal or pandemic H1N1 influenza vaccines administered parenterally (4 studies) or intranasally (1 study with a toxin-adjuvanted vaccine), BNT162b2, a mRNA COVID-19 vaccine (1 disproportionality analysis and 1 observed-to-expected analysis) and an inactivated virus COVID-19 vaccine (CoronaVac®) (1 study combining a case-control and an observed-to-expected approach). Strong evidence was found only for the intranasal influenza vaccine while other positive studies detected only a marginal association between PFP and vaccination. Of the four case reports with documented rechallenge, only two were positive and involved an influenza vaccine and tozinameran in one case each. In Vigibase, rechallenge was documented in 49 reports with 29 (59.2%) cases being negative and 20 (40.8%) positive. The available data did not confirm an excess risk of PFP after vaccination in most studies. Moreover, of the eight epidemiological studies suggesting a possible excess risk of PFP after any vaccine, three were disproportionality analyses and two observed-to excepted analyses, suggesting great caution should be taken when interpreting these results.
Insights
The association between vaccines and peripheral facial palsy (PFP) is debated. Most studies found no excess risk of PFP after vaccination, with limited evidence for some influenza and COVID-19 vaccines.
Area of Science:
- Immunology and Vaccinology
- Neurology and Epidemiology
Background:
- The potential link between vaccinations and peripheral facial palsy (PFP) has been a long-standing discussion, recently reignited by mRNA COVID-19 vaccines.
- Understanding vaccine safety regarding PFP is crucial for public health and vaccine confidence.
Approach:
- A comprehensive literature search of PubMed was conducted from inception to February 25, 2022, including case reports with rechallenge and comparative epidemiological studies.
- Data on COVID-19 vaccine-associated PFP with rechallenge information were also extracted from Vigibase up to December 31, 2021.
- Studies were analyzed for associations between various vaccines, including influenza and COVID-19 vaccines, and the occurrence of PFP.
Key Points:
- Out of 32 comparative epidemiological studies and 4 case reports meeting inclusion criteria, 13 involved COVID-19 vaccines.
- Eight studies suggested an association between certain vaccines (influenza, mRNA COVID-19, inactivated COVID-19) and PFP, while 24 found no association.
- Strong evidence for an association was identified only for intranasal influenza vaccines; other positive findings indicated only a marginal link.
Conclusions:
- The available data largely do not confirm an increased risk of PFP following vaccination.
- Rechallenge data from Vigibase showed a higher proportion of negative outcomes (59.2%) compared to positive (40.8%).
- Caution is advised when interpreting studies suggesting an excess risk, particularly disproportionality and observed-to-expected analyses.
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Microorganisms in Medicine and Therapeutics

